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Summary.-The lability of cell surface histocompatibility antigens of 2 murine
lymphomata was examined. These 2 tumours differ greatly in their capacity to
metastasize in syngeneic hosts. Cells of the metastatic lymphoma released histo-
compatibility antigens in vivo and in vitro at a greater rate than cells of the non-
metastasizing lymphoma. Antigen/antibody complexes formed by the addition of
allo-antiserum to intact cells disappeared more rapidly from the surface of cells of
the metastatic line. We propose that the instability of surface antigens may be an
integral feature of malignant cells and that there may be a quantitative relationship
between the lability of membrane components and the capacity of the tumour to
metastasize.
THE RATE of release of tumour specific
transplantation antigens (TSTA) into the
supernatants of rat fibrosarcoma cell
cultures was found to be greater from a
cell line which metastasizes in vivo than
from one which does not (Currie and
Alexander, 1974).
In the study presented here, the
turnover of histocompatibility antigens at
the surface of murine lymphoma cells
with differing metastatic capacity was
investigated by measuring (1) the sponta-
neous shedding of these antigens into the
supernatants of cultured cells, (2) their
appearance in the serum of tumour-
bearing animals and (3) by determining the
rate at which antigen/antibody complexes
formed with specific allo-antisera were lost
from the cell surface.
MATERIALS AND METHODS
Tumours.-The tumours studied Mwere 2
transplantable ascitic lymphomata syngelleic
in inbred DBA2 female mice. The L5178Y/E
was induced with methylcholanthrene and
introduced to this laboratory in 1961, where
it is maintained by weekly in vivo passage
with frequent recourse to early passages
stored in liquid nitrogen. It is highly
immunogenic in syngeneic mice although it is
now unclear as to whether this is due to a
potent TSTA or to genetic drift between our
animal colony and the colony in which it
arose. It rarely metastasizes from a sub-
cutaneous (s.c.) implant and for brevity will
be referred to as the non-M line. Death in
4-5 weeks follows s.c. inoculation of 106 cells
and the tumour nodule grows progressively to
3 cm or more in diameter. The tumour with
which it was compared is the L5178Y/ES,
referred to as the M lymphoma, which arose
spontaneously during routine passage of the
non-M lymphoma. It differs from the parent
line (Parr, 1972) in being only feebly immuno-
genic in syngeneic mice and in metastasizing
rapidly from a s.c. implant, principally to the
liver and spleen. Death from metastasis
occurs within 7-10 days following s.c.
injection of 106 cells. The striking differences
in biological behaviour of these 2 lympho-
mata are unlikely to be due to intrinsic
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FIG. la.-Complementdependentcytotoxicity
ofCBA anti-DBA2, anti-C57BI double allo-
antiserum on SL2 target cells (DBA2
lymphoma) titrated in the presence ofaddi-
tional medium * 0, or 1 : 2dilution
of culture supernatant from cultures of
DBA2 spleen cells A. A, non-M
lymphoma cells - * * and M
lymphoma cells 0 --- 0.
differences in their doubling times since
assaysoftheirgrowthintheascitic form reveal
remarkably similar growth kinetics.
Histocompatibility antigen assay.-Histo-
compatibility antigen activity in tumour cell
culture supernatants and sera was assessed
by their capacity to inhibit in a specific
manner the cytotoxic activity of allo-
antiserum in a complement dependent test
system. Strain specificity of the inhibition
was determined by using an allo-antiserum
raised against both the tumour-host strain
(DBA2) and an unrelated strain (C57B1)
differing at the H-2 locus. The use of this
double antiserum enabled us to rule out
nonspecific effects in the inhibition of
cytotoxicity. The extent of specific abroga-
tion oftoxicity for DBA2 target cells without
any effect onthe lysis ofC57B1 cells, achieved
by mixing the double antiserum with culture
supernatant or serum, was used as a measure
of the concentration of free histocompati-
bility antigen.
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Fig. lb.-As la; target cells = TLX-9 (C57B1
lymphoma).
The allo-antiserum was raised in CBA
female mice by the intraperitoneal (i.p.)
injection of 1.5 x 107 DBA2 spleen cells
admixed with the same number of C57B1
spleen cells. Such injections were given on
Days 0, 14, and 21 and the mice were bled on
Day 28. The antiserum was highly cytotoxic
in the presence of complement when tested
on target cells from DBA2 or C57B1 mice but
had no activity on CBA or A strain cells, all
4 strains differing at the H-2 locus.
Serial dilutions of the antiserum were
prepared in medium 199 (Wellcome) plus
10% foetal bovine serum (Biocult), and were
mixed with equal volumes of culture super-
natant or tumour bearing serum in LP3
tubes (Luckham), bringing the final volume
to 0-2 ml. The mixture of antiserum plus
supernatant or tumour bearing serum was
pre-incubated overnight at 40C, then allowed
to return to room temperature. To each tube
was added 0-05 ml washed target cells at
3 x 106/ml, in complete medium. The
target cells were either SL2 ascitic lymphoma
syngeneic in DBA2 mice or TLX-9 ascitic
lymphoma syngeneic in C57B1 mice. After
mixing, the cells were left at room tempera-
ture for 30 min, then centrifuged, the super-
natants removed and the cells washed once in
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1 ml medium 199, ensuring that prozone
effects were not encountered. Complete
medium with 500 absorbed weanling rabbit
serum as a cource of complement was then
added and the cells incubated at 37°C for
20 min, before being spun down and re-
suspended in a freshly prepared 0-057%
trypan blue solution. After 5 min at room
temperature the tubes were placed on ice and
a differential count was made oflive and dead
cells in each sample.
Culturesupernatants.-Tumour cellculture
supernatants were prepared by incubating
extensively washed lymphoma cells at 2-5 x
107/ml in 5 ml volumes in disposable plastic
flasks (Falcon) for 3 h at 37°C in an atmo-
sphere of20% Co2 in air. The culture medium
employed was TC 199 supplemented with
10% foetal bovine serum. Viability of the
cells by trypan blue exclusion was always
greater than 9000 and was not reduced by
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FIG. 2. Complement dependent cytotoxicity
of CBA anti-DBA2, anti-C57BI double
allo-antiserum on SL2 target cells (DBA2
lymphoma), titrated in the presence of
additional culture medium * *, of
1: 4 dilution of culture supernatant from
cultures of DBA2 spleen cells A ...... A
MI lymphoma cells 0 ----0, or a mix-
tutre ofequalvolumes ofthese 2 supernatants
pre-iiLcubated at, room temperatLure for I h
blefore ad(ling to the antisertum,
A *.
this brief incubation. Such short-term
cultures were employed because we have
found it impossible to maintain the M-
lymphoma in longer term cultures. Super-
natants were also collected from similar
cultures of normal DBA2 spleen cells. All
supernatants were passed through 0-22 /tm
Millipore filters before storino in small
aliquots at -20°C; samples were used imme-
diately after thawing and were not refrozen.
Tumour bearing serum-.Tumour bearing
sera were collected and pooled from 5-10
mice 8 days after i.p. inoculation of2-5 x 105
lymphoma cells. At that time the peritoneal
cavities of mice bearing either tumour
contained approximately 5 x 108 tumour
cells.
Antigenic modulation assay.-Lymphoma
cells were suspended for 30 min at room
temperature in diluted anti-DBA2 allo-
antiserum raised in C57B1 mice. Cell
concentration, culture medium and culture
vessels were as described previously for the
histocompatibility antigen assay. Following
exposure to various titres of antibody the
cells were washed, resuspended in 0-2 ml
fresh culture medium and incubated at 37°C
for 2, 4 or 6 h. After a second wash, com-
plement-containing medium was added as
before and cytotoxicity assessed by trypan
blue exclusion.
RESULTS AND DISCUSSION
Shedding of histocompatibility antigens
Figure 1 shows that pre-incubation of
the double antiserum with culture super-
natant from cells of the M lymphoma
significantly reduced complement depen-
dent cytotoxicity for the DBA2 target
cells (SL2), without a corresponding effect
on the cytotoxicity of the same antiserum
for C57B1 target cells (TLX-9), i.e. there
was strain-specific abrogation of cyto-
toxicity. Culture supernatants from non-
M cells were totally inactive. Normal
DBA2 spleen cell supernatants occa-
sionally contained low levels ofnonspecific
inhibitory activity which was removed by
ultracentrifugation at 100,000 rev/min for
30 min, whereas the specific activity of
culture supernatants from the M line was
unaltered by this procedure. To test if
absence of detectable specific activity in
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Fie. 3a.-Complement (lependent cytotoxi-
city of CBA anti-DBA2, anti-C57Bl (louble
allo-antiserum on SL2 target cells (DBA2
lymphoma), titratedl in the presence of
additional culture medium * 0,
of 1: 2 dilution of normal DBA2 serum
A . A, or tumour bearing serum
from mice M ith ascitic non-M lymphoma
- * * A, or MVI lymphoma
0 - - - - O
supernatants from normal spleen cells was
due to degradation of released antigen by
hydrolytic enzymes, an inactive spleen
cell supernatant was mixed with a speci-
fically active supernatant from cultured
M cells, before addition to the antiserum.
This procedure did not alter the specific
inhibitory activity of the M cell super-
natant and therefore it is unlikely that the
release of degradative enzymes by spleen
cells in vitro contributes to the lack of
detectable histocompatibility antigen in
spleen cells supernatants (see Fig. 2).
Enzymatic degradation of the antibody
by MI cell supernatants is excluded by the
demonstation of strain specificity of the
inhibition obtained.
Sera from mice bearing ascitic M
tumour produced substantially greater
inhibition of lysis of DB)A2 target cells byr
alloanitibody than did sera from control
250 500 1000 2000
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Fi(e. 3b. As 3a; target cells = TLX-9 (C57BI
lymphoma).
mice or mice bearing the non-M lymphoma
(see Fig. 3). The detection of histo-
compatibility antigens in the serum of
normal DBA2 mice accords with observa-
tions that soluble HL-A antigens appear
in the sera ofnormal individuals (Charlton
and Zmijewski, 1970; van Rood, van
Leeuwen and van Santen, 1970).
The shedding of histocompatibility
antigens from murine lymphomata with
differing metastatic capacity described
here may be a parallel to the shedding of
TSTA from rat fibrosarcomata, wlhere in
vitro TSTA could only be detected in the
culture supernatant of the metastatic
tumour (Currie and Alexander, 1974),
although in vivo both non-metastatic and
metastatic tumour bearing rats had TSTA
in their serum (Thomson, Steele and
Alexander, 1973).
Modulation
We also examined the behaviour of
surface histocompatibility antigens after
exposure to specific allo-antibody. The
rate of elimination- of antigen/antibody
complexes formed at the cell surface by
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Flt'I. 4a. Complement dependent cytotoxi-
city of C57BI anti-DBA2 allo-antiserum on
M lymphoma cells, incubated in antibody-
firee medium for 0 h * 0, 2 h
A. A, 4 h A
--A--- or 6 h
0 O, following exposure to the
antiserum.
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FIG. 4b.-
phoma.
16000
-As 4a; target cells= non-M lym-
the addition of allo-antiserum was deter-
mined by the methoddescribedbyBernoco
and his colleagues (1971), in which
complement is added to cells previously
coated with antibody after varying periods
of culture in antibody-free medium.
Figure 4 shows that antibody rapidly
disappeared from the surface ofthe M cells
whereas non-M cells remained susceptible
to complement mediated lysis even after
6 h incubation. M cells from which
antibody had completely disappeared after
4 h incubation were as susceptible to lysis
by fresh antiserum and complement as
unmodulated M cells. This suggests that
antigen is replaced at the cell surface as
rapidly as it is lost in combination with
antibody, or, in Ceppellini's terminology,
" stripped ".
Susceptibility to antibody-mediated lysis
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FIG. 5. Complement dependent cyt
of C57B I anti-DBA2 allo-antiserun
on non-M lymphoma cells 0
M lymphoma cells C).
I, The rapid disappearance of antigen/
000 16000 antibody complexes from the surface of M
;erum cells prompted us to measure complement
;otoxicity dependent antibody mediated lysis of the
ntitrated 2 cell lines. It is apparent from Fig. 5 that
0, and
cells of the M line are more resistant to
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lysis by allo-antibody and complement
than non-M cells. The difference in the
concentration of antiserum required to
produce 50%0 cytotoxicity could be an-
other reflection of the greater lability of
histocompatibility antigens in the mem-
brane ofM cells. It is unlikely that M cells
simply have fewer surface histocompati-
bility antigens, since we have shown that
these cells are more effective than non-M
cells in absorbing the specific anti-DBA2
activity of the antiserum used in the lytic
assay.
CONCLUSION
These data are consistent with the
hypothesis that the rate of turnover of
tumour cell membrane antigens is related
to the biological behaviour of the tumour
in vivo, i.e. its immunogenicity and
capacity to metastasize. This investiga-
tion of histocompatibility antigen lability,
taken together with the earlier study of
TSTA in a rat system, suggests that it is
the behaviour of the cell membrane as a
whole and not only of the tumour specific
determinants which may distinguish a
metastatic tumour from one which fails to
metastasize.
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